HHMI
DEO icon

Howard Hughes Medical Institute’s Diageo DEO Stock Holding History

Howard Hughes Medical Institute’s Portfolio DEO Stock Details DEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,000
Closed -$4.75M – 23
2022
Q3 		$4.75M Buy
+28,000
New +$5.02M 1.35% 30

Other funds holding DEO

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return

Howard Hughes Medical Institute's DEO Position: Q4 2022 in Review

Howard Hughes Medical Institute sold out of Diageo (DEO) in Q4 2022, closing a stake of 28,000 shares — an estimated $4.75M sold.

Howard Hughes Medical Institute first reported a position in DEO in Q3 2022 and held it in 1 quarter. The position peaked at $4.75M in Q3 2022. 1,019 funds tracked by Wall St. Rank hold DEO as of Q4 2022.

  • Howard Hughes Medical Institute reported no remaining Diageo position as of Q4 2022 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 28,000 Diageo shares in Q4 2022, an estimated $4.75M.
  • Howard Hughes Medical Institute first reported a position in Diageo in Q3 2022 and held it in 1 quarter.
  • Howard Hughes Medical Institute's Diageo position peaked at $4.75M in Q3 2022.
  • 1,019 funds tracked by Wall St. Rank held Diageo as of Q4 2022.

Based on Howard Hughes Medical Institute's 13F filing for Q4 2022, filed 14 Feb 2023.